Graduate Faculty Directory
Judith Johnson
Department of Pharmaceutical and Healthcare Business
Education
- BS (Siena College)
- MS (Rensselaer Polytechnic Institute)
- MBA (University of the Sciences in Philadelphia)
Faculty Appointments
Adjunct Assistant Professor of Pharmaceutical Business
Professional Information
Director of Pharmacokinetics
Vitae Pharmaceuticals, Inc.
Synopsis
Judy is currently working for an emerging pharmaceutical company in Fort Washington, PA, where she is working with the business and scientific teams to advance Vitae’s product candidates and accelerate the development of the company’s rapidly growing pipeline of exciting compounds.Prior to joining Vitae in April 2006, Judy was Director of Clinical Pharmacology and Pharmacokinetics at GE Healthcare Bio-Sciences, a $3 billion business of GE Healthcare focused on medical diagnostics, drug discovery and protein separation systems. She has also served as Director of the Drug Metabolism and Pharmacokinetics Section of Biological Sciences and was a member of Biological Sciences Senior Management Team. With 25+ years of pharmaceutical industry experience, Judy’s expertise in drug development combined with her ability and appreciation for business operations produces an accomplished blend of technical, analytical and management skills. She has contributed to the successful registration of several novel drug products.
Publications & Presentations
- Sherwin PF, Cambron R, Johnson JA and Pierro JA. Contrast Dose-to-Creatinine Clearance (D/CrCL) Ration as a Potential Indicator of Risk for Radiocontrast-Induced Nephropathy: Correlation of D/CrCL with Area Under the Contrast Concentration-Time Curve (AUC) using Iodixanol. Investigative Radiology (2005) 40:598-603.
- Johnson WH, Lloyd TR, Victoria BE, Zales VR, Epstein ML, Leff RD, Ardinger RH, Slovis TL, Johnson JA and Marsters PA. Iodixanol Pharmacokinetics in Children. Pediatr Cardiol (2001) 22:223-227.
- Wu D, Berna M, Maier G, Johnson J. An Automated Multidimensional Screening Approach for Rapid Method Development in High Performance Liquid Chromatography. J. Pharm Biomed. Anal. 16 (1997) 57-68.
- Hlasta DJ, Subramanyam C, Bell MR, Carabateas PM, Court JJ, Desai RC, Drozd ML, Eickhoff WM, Ferguson EW, Gordon RJ, Johnson JA, Kumar V, Maycock AL, Mueller KR, Pagani ED, Robinson DT, Saindane M, Silver PJ and Subramanian S. Orally Bioavailable, Benzisothiazolone Inhibitors of Human Leukocyte Elastase. J Med Chem. 1995: Vol. 38, No. 5, 739-744.
- Singh J, Conzentino P, Cundy K, Gainor JA, Gilliam C, Gordon TD, Johnson JA, Morgan BA, Schneider E, Wahl R and Whipple D. Relationship Between Structure and Bioavailability in a Series of Hydroxamate Based Metalloprotease Inhibitors. Bioorganic and Medicinal Chemistry Letters, 1995: Vol. 5, Nov. 4, 337-342.
- Fountaine H, Marsters P, Johnson J, Bini P, Robison RO and Cautreels W. A Phase I, Open-Label, Multicenter, Pharmacokinetic and Safety Study of VISIPAQUE (Iodixanol) Injection 320 MgI/mL in Pediatric Patients Referred for a Contrast-Enhanced Diagnostic Procedure, Oral Presentation at CMR, June 1997.
- Working PK, Newman MS, Johnson J and Cornacoff JB. Safety of Poly(ethylene glycol) and Poly(ethylene glycol) Derivatives. in Poly(ethylene glycol) Chemistry and Biological Applications ACS Symposium Series Ed. by JM Harris and S Zalipsky (1997)4:45-57.
- DiNoto DR, Kennedy CD, Johnson JA, Sherwin PF, Ballerini R, Anderson K and Newton JF. Pharmacokinetics and Biotransformation of the MRI Liver Contrast Agent Mangafodipir Trisodium Injection in Normal Human Male Volunteers. Proceedings of the Forth International ISSX Meeting, 1995:323.
- Robinson DT, Boyling LM, Rich CG, Blackmore M, Gray TJB, Greenslade D, Oppermann JA, Olson HM and Johnson JA. In Vitro/In Vivo Metabolism of a Novel Human Leukocyte Elastase Inhibitor. Proceedings of the Fourth International ISSX Meeting, 1995:59.
- Olson HM, Johnson J, Opperman J, Reddy V, Greenslade D, Gallas JF, Rees J, Robinson DT, Wimberly HC and Gray TJB. Species Differences in Toxicity of a Human Elastase Inhibitor. Society of Toxicology Meeting, Baltimore, MD, March 1995.
Phone: 215.461.2064
Email: judithjohnson@comcast.net
